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After publication of this article [1], the editor noticed 
two errors in Figure  1. The word “Vemintin” should be 
“Vimentin” and “E-caderin” should be “E-cadherin”. The 
correct version of Fig. 1 can be found in this erratum.
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Fig. 1 Schematic model of lymphocyte‑specific helicase (LSH) in cancer progression. LSH promotes cell growth, migration, and invasion, which 
are characteristics of cancer progression. The effect of LSH is, in part, mediated by fumarate hydratase (FH), through the intact combination of LSH 
and euchromatic histone‑lysine N‑methyltransferase 2 (G9a). FH repression, in turn, leads to changes of tricarboxylic acid cycle (TCA) intermediates, 
including succinate, fumarate, and malate, and an increase in the ratio of α‑ketoglutarate (α‑KG) to fumarate. TCA intermediates promote migration, 
invasion, and epithelial–mesenchymal transition (EMT) through the decrease of E‑cadherin and tight junction protein ZO‑1 and the increase of 
vimentin. The changes of E‑cadherin and ZO‑1 are mediated by inhibitor of nuclear factor kappa‑B kinase alpha (IKKα), which directly binds to these 
promoters
Page 2 of 2Liu and Tao  Chin J Cancer  (2016) 35:99 
Author details
1 Center for Medicine Research, Xiangya Hospital, Central South University, 
Changsha 410008, Hunan, P. R. China. 2 Cancer Research Institute, School 
of Basic Medicine, Central South University, Changsha 410078, Hunan, P. R. 
China. 3 Key Laboratory of Carcinogenesis and Cancer Invasion (Central South 
University), Ministry of Education, Changsha 410078, Hunan, P. R. China. 
Received: 3 November 2016   Accepted: 3 November 2016
Reference
 1. Liu S, Tao YG. Chromatin remodeling factor LSH affects fumarate 
hydratase as a cancer driver. Chin J Cancer. 2016;35:72. doi:10.1186/
s40880‑016‑0138‑7.The online version of the original article can be found under  
doi:10.1186/s40880‑016‑0138‑7. 
